Facebook
Twitter
LinkedIn
Forward
Upcoming Events
Recent courses
Obesity is a chronic, serious life threatening disease, but treatments exist. Obesity is associated with an increased risk of CVD and CV-associated mortality.
|
In June of 2023 the AASLD updated the nomenclature for NAFLD to Metabolic dysfunction-Associated Steatotic Liver Disease(MASLD).
|
Join Dr. Angela Fitch for this Obesity Care Week webinar to dissect and raise awareness of the complexities of obesity from a medical perspective.
|
Pages
The material presented by the Obesity Medicine Association (OMA) is for educational purposes only. Opinions expressed do not necessarily reflect those of OMA. The material is not intended to represent the only or necessarily best method or procedure appropriate for the medical situations discussed. Instead, it is intended to present an approach, view, statement, or opinion of the faculty that may be helpful to others who face similar situations. The individual is responsible for becoming familiar with laws and prescribing limitations within his or her own state before practicing various therapies. OMA also presents a forum for its members to be exposed to various products and services. It is the responsibility of each attendee or member to do due diligence, including reviewing literature, lectures, and background information.
OMA disclaims any and all liability for injury or other damages resulting to any individual viewing pages on obesitymedicine.org or academy.obesitymedicine.org and for all claims that may arise out of the use of the techniques demonstrated therein by such individuals, whether these claims shall be asserted by physician or any other person.